Moderna to build new mRNA vaccine manufacturing facility in Canada
Biotechnology firm Moderna and Canadian government have signed a memorandum of understanding (MoU) to construct a new messenger RNA (mRNA) vaccine manufacturing facility in Canada.
Biotechnology firm Moderna and Canadian government have signed a memorandum of understanding (MoU) to construct a new messenger RNA (mRNA) vaccine manufacturing facility in Canada.
Amgen has announced plans to construct a new multi-product drug substance manufacturing facility in Holly Springs, North Carolina, the US.
Pfizer and BioNTech have signed a letter of intent with The Biovac Institute, the South African biopharmaceutical company, to jointly manufacture and distribute their Covid-19 Vaccine in the African Union.
Eli Lilly and Company is set to acquire the remaining shares of biotech firm Protomer Technologies in a deal valued more than $1bn.
The Russian Direct Investment Fund (RDIF) has collaborated with Serum Institute of India (SII) to produce Sputnik V Covid-19 vaccine in India.
Philip Morris International (PMI) has agreed to acquire British pharmaceutical firm Vectura Group for about $1.183bn (£852m) to expand its product pipeline development capabilities in inhaled therapeutics.
Verge Genomics has announced a three-year partnership with Eli Lilly and Company to discover and develop novel therapies for amyotrophic lateral sclerosis (ALS), a motor neuron disease.
The Russian Direct Investment Fund (RDIF) has announced the production of a test batch of the Russian Covid-19 vaccine, Sputnik V, in Mexico.
Philip Morris International has signed an agreement to acquire Fertin Pharma from private equity firm EQT for approximately $812.8m (DKK5.1bn).
The International Finance Corporation (IFC) has announced a joint financing package of $712.67m (€600m) for Aspen Pharmacare to support the Covid-19 vaccines production.